Business
Know the Business — Supreme plc (SUP)
Supreme is a UK FMCG distributor that has, almost by accident, become a vertically integrated brand owner. The economic engine is a value-priced, high-velocity, low-assortment platform that sells whatever its retail customers (B&M, Home Bargains, Poundland, Tesco, Sainsbury's, Asda, Aldi) will put on the shelf at a sub-premium price. The market currently underestimates two things: (1) that Vaping is a cash machine even after the disposable ban, and (2) that "branded distribution" margin compression hides genuine operating leverage on the in-house manufactured base.
How This Business Actually Works
Supreme makes money in three different ways inside one corporate skin, and confusing them is the most common analytical error.
The Electricals business (Duracell, Energizer, Panasonic batteries plus licensed lighting under Eveready, Black & Decker, JCB) is a low-margin, low-overhead door-opener. Roughly 35% UK battery share, near-zero incremental cost — it earns Supreme its slot in every retailer's electrical aisle. Drinks & Wellness (SCI-MX sports nutrition, vitamins, plus the FY24 Clearly Drinks and FY25 Typhoo Tea / SlimFast acquisitions) is an in-house manufactured branded-goods business with classic FMCG margins. Vaping — both 88Vape (own-brand, manufactured at up to 4.5 million bottles of e-liquid per week) and the master distribution agreement for ElfBar / Lost Mary — is the cash engine: 56% of FY25 revenue, 36% gross margin on the owned half, much thinner on the third-party distribution half.
Incremental profit comes overwhelmingly from two things: (1) cross-selling new categories down the existing customer pipeline, where overhead barely moves; and (2) acquiring brands (Battle Bites, SCI-MX, Liberty Flights, Cuts Ice, Clearly Drinks, Typhoo Tea, SlimFast) at 2-4x post-synergy EBITDA and putting them through the central platform. Bargaining power is modest with the big grocers but strong with discounters, where Supreme's price/quality combination has become structurally important.
Mental model: Think of Supreme as a single warehouse, a single sales team, and a single retailer rolodex — with a rotating cast of branded SKUs running across it. The platform is the asset; the brands are inventory.
The Playing Field
There is no clean comp. Supreme is a hybrid of a soft-drinks brand owner, a private-label household manufacturer, and a vape distributor — so peers are read across three industries.
What the peer set reveals: Supreme earns soft-drink-like ROCE (around 40%) on McBride-like revenue per pound of capital, while trading at McBride's multiple. Nichols (Vimto) and AG Barr (Irn-Bru) are the real anchors — branded UK FMCG businesses with similar margin shape but trade at roughly twice the EV/EBITDA. Applied Nutrition has the cleanest single-category profile and the highest margin of the group, which is why it earns a 10x+ multiple. McBride is the cautionary tale: high ROCE only because equity has been depleted; the low multiple reflects that. The "good" version of Supreme is a Nichols-margin, BAG-multiple business — a path that depends on Drinks & Wellness, not Vaping, becoming the dominant gross-profit pool.
Is This Business Cyclical?
Mildly cyclical at the topline, far less cyclical at the gross-profit line, and almost not cyclical at the cash-flow line — because the categories are consumer staples sold predominantly through value retailers that thrive in downturns.
The two cycles that actually matter for Supreme are not GDP cycles — they are regulatory and inventory. The 2023 lighting collapse (43% revenue decline that year) was a customer-destocking event, not end-demand. The 2024-2026 vaping cycle has been a regulatory transition: HMRC excise duty proposed in 2024, disposable ban effective June 2025, vape levy due October 2026. Disposable revenue dropped from £71m (FY24) to £54m (FY25); the company guided this carefully and avoided stock writedowns. Working capital and inventory turnover behavior has been noisy because of this — inventory turnover ran from 6.3x in FY24 to 5.2x in FY25 as the mix transitioned to pods.
The lesson: the bottom-line shock from a regulatory event is much smaller than the headline revenue shock, because (a) the disposable consumer migrates to refillable pods at the same price point with a similar gross-margin profile, and (b) discounters absorb price increases on staples categories.
The Metrics That Actually Matter
Three metrics carry almost all the signal. Forget reported P/E in isolation.
P/E and EV/Sales miss the point. Supreme's reported P/E of around 8x is meaningless without segmenting Vaping cash from non-Vaping cash. The right way to think about it is: how many pounds of gross profit does the central platform generate per pound of SG&A overhead, and how does that ratio scale as the next acquisition is bolted on. That ratio sits at 16-20x and has not deteriorated as the company tripled in size.
What Is This Business Worth?
Supreme is best valued as two distinct economic engines under one roof — and the consolidated multiple deserves to be a weighted blend, not a single number. Vaping is a regulated, terminal-value-impaired cash cow worth a low-single-digit EBITDA multiple. The non-Vaping platform (Drinks & Wellness + Electricals + central platform leverage) deserves a mid-teens earnings multiple consistent with Nichols and AG Barr.
The stock makes sense if Drinks & Wellness compounds into the dominant gross-profit pool over the next three years; it does not make sense if Vaping is the entire thesis. The market is pricing it as the latter. The single number that would justify a re-rating to a Nichols/BAG multiple is non-Vaping gross profit crossing £40m — at FY25 it was around £25m, growing fast through M&A.
What I'd Tell a Young Analyst
Watch gross profit by category, not revenue. Watch acquisition multiples, not deal counts. Watch the ratio of gross profit to SG&A — if Supreme's platform thesis is real, that ratio holds steady as the company grows; if it's a typical roll-up, it collapses. Three things would change the thesis: (1) a Sandy Chadha succession event (he's both the operator and the deal sourcer — concentrated key-person risk), (2) a vaping levy structure that taxes refillable pods as harshly as disposables (currently expected to be lighter), (3) signs that any acquisition is being integrated badly — measured by gross margin compression in the acquired category 12 months in. The cleanest bull/bear test is the FY26 guidance for Drinks & Wellness gross profit. Below £15m: the diversification story is stalling. Above £20m: Supreme is no longer a vape stock.